NCT05236673Completed
Jardiance® Post Marketing Surveillance (PMS) in Korean Patients With Chronic Heart Failure
A Regulatory Requirement Non-interventional Study to Monitor the Safety and Effectiveness of Jardiance® (Empagliflozin, 10mg) in Korean Patients With Chronic Heart Failure (NYHA Class II-IV)
Source: ClinicalTrials.gov · Last updated 10 Aug 2026
Brief summary (registry, in English)
The primary objective of this study is to monitor the safety profile of Jardiance® in Korean patient with chronic heart failure (New York Heart Association (NYHA) class II-IV) in a routine clinical setting.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 676 (actual)
- First submitted
- 2 Feb 2022
- Start date
- 28 Jul 2022
- Primary completion date
- 30 Apr 2025
- Lead sponsor
- Boehringer Ingelheim
- Diseases
- Heart failure
- NCT number
- NCT05236673
What you commit to
- Study type: Observational
- Participants enrolled: 676
- From 28 Jul 2022 to the primary completion date, 30 Apr 2025
- 21 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with previous exposure to Jardiance®
- Patients with type 1 diabetes or with prior history of diabetic ketoacidosis (DKA)
Other illness
- Known allergy or hypersensitivity to active ingredients empagliflozin or to any of the excipients
Lab values
- Patient with renal impairment with estimated Glomerular Filtration Rate (eGFR) \< 20 mL/min/1.73 m²
- Patients with rare hereditary conditions of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption
Other
- Patient who are pregnant or are nursing or who plan to become pregnant while in the trial
- Patients for whom empagliflozin is contraindicated according local label of Jardiance®
Who the study is looking for
- Patients who have started at first time on Jardiance® in accordance with the approved label in Korea for heart failure (HF)
- Chronic heart failure (New York Heart Association (NYHA) class II-IV)
- Age ≥ 19 years at enrolment
- Patients who have signed on the data release consent form
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (21)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hallym University Medical Center Coordinator of this site? Confirm its status | Anyang-si, Gyeonggi-do | South Korea | Unknown status |
| Pusan National University Hospital Coordinator of this site? Confirm its status | Busan | South Korea | Unknown status |
| Inje University Haeundae Paik Hospital Coordinator of this site? Confirm its status | Busan | South Korea | Unknown status |
| Inje University Busan Paik Hospital Coordinator of this site? Confirm its status | Busan | South Korea | Unknown status |
| Pusan National University Yangsan Hospital Coordinator of this site? Confirm its status | Busan | South Korea | Unknown status |
| Kangwon National University Hospital Coordinator of this site? Confirm its status | Chuncheon-si, Gangwon-do | South Korea | Unknown status |
| Kyungpook National University Hospital Coordinator of this site? Confirm its status | Daegu | South Korea | Unknown status |
| Yeungnam University Medical Center Coordinator of this site? Confirm its status | Daegu | South Korea | Unknown status |
| Chungnam National University Hospital Coordinator of this site? Confirm its status | Daejeon | South Korea | Unknown status |
| Inje University Ilsan Paik Hospital Coordinator of this site? Confirm its status | Goyang-si, Gyeonggi-do | South Korea | Unknown status |
| Dongguk University Medical Center Coordinator of this site? Confirm its status | Goyang-si, Gyeonggi-do | South Korea | Unknown status |
| Chonnam National University Hospital Coordinator of this site? Confirm its status | Gwangju | South Korea | Unknown status |
| Jeonbuk National University Hospital Coordinator of this site? Confirm its status | Jeonju-si, Jeollabuk-do | South Korea | Unknown status |
| The Catholic University of Korea, Seoul ST. Mary's Hospital Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
| Asan Medical Center Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
| VHS Medical Center Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
| Severance Hospital, Yonsei University Health System Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
| Korea University Anam Hospital Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
| Seoul National University Boramae Medical Center Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
| Samsung Medical Center Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
| The Catholic University of Korea, Uijeongbu ST. Mary's Hospital Coordinator of this site? Confirm its status | Uijeongbu-si, Gyeonggi-do | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.